Directive transparence : information réglementée

30/04/2019 08:14

DGAP-News: SINGULUS TECHNOLOGIES AG / Key word(s): Incoming Orders
SINGULUS TECHNOLOGIES Receives New Order for Medical Technology

30.04.2019 / 08:14
The issuer is solely responsible for the content of this announcement.

Press Release

SINGULUS TECHNOLOGIES Receives New Order for Medical Technology

Kahl am Main, April 30, 2019 - The SINGULUS TECHNOLOGIES AG (SINGULUS TECHNOLOGIES) has received a new order from a European customer for the delivery of two processing machines for the cleaning of medical products. The order volume is in the mid-single-digit million Euro range. SINGULUS TECHNOLOGIES is thus able to further establish itself in the market for medical technology.

Dr. Stefan Rinck, CEO of the SINGULUS TECHNOLOGIES AG, comments: "The successful entry into medical technology was an important step for our company. Here, we were able to benefit from our extensive know-how of the treatment of surfaces, which includes the cleaning, structuring and coating of sophisticated products." Dr. Rinck adds: "The orders for the new work areas Decorative Coating and Medical Technology show that we continue to consistently implement our plans for additional diversification."

For medical technology SINGULUS TECHNOLOGIES offers machine technology for wet-chemical processes and methods of vacuum coating technology. All processes share the basic idea of an efficient and resource-friendly production technology.

SINGULUS TECHNOLOGIES - Innovations for New Technologies
SINGULUS TECHNOLOGIES develops and assembles innovative machines and systems for efficient and resource-saving production processes, which are used worldwide in the solar, semiconductor, medical technology, consumer goods and optical disc sectors.

The company's core competencies include various processes of coating technology, surface treatment and wet-chemical and thermal production processes.

SINGULUS TECHNOLOGIES AG, Hanauer Landstrasse 103,
D-63796 Kahl/Main, WKN A1681X / ISIN DE000A1681X5
Maren Schuster, Investor Relations, Tel.: + 49 (0) 160 9609 0279
Bernhard Krause, Corporate Communications, Tel.: + 49 (0) 1709202924
Email: bernhard.krause@singulus.de

30.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Hanauer Landstrasse 103
63796 Kahl am Main
Phone: +49 (0)1709202924
Fax: +49 (0)6188 440-110
E-mail: bernhard.krause@singulus.de
Internet: www.singulus.de
ISIN: DE000A1681X5, DE000A2AA5H5
WKN: A1681X, A2AA5H
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 804897

End of News DGAP News Service

804897  30.04.2019